Stifel analysts confirmed their Buy rating on Denali Therapeutics Inc. (NASDAQ:DNLI) with a steady price target of $37.00. According to InvestingPro data, analysts maintain a Strong Buy consensus with ...

CurePSP awarded CARES grants for multi-center projects aimed at improving care, access, and education for patients with PSP, ...

Scientists at Southern Methodist University have uncovered new clues about Sudden Unexpected Death in Epilepsy (SUDEP), a ...

New research suggests that Alzheimer’s disease damages the brain in two separate phases, with the first phase happening ...

People with insomnia can have frequent difficulty falling asleep, staying asleep, and getting good-quality sleep.

These are known as disease-modifying treatments and have been licensed for private use. Other medications are under review to see if they could be prescribed to people in the very early stages of ...